Hank:
I do totally agree with you that their may be other brillant scientist out there who could more than adequately feel Babish shoes. I also agree with you that other very competant scientist have worked with him and know his "trade secrets."
So far though, we have Alfred Alberts, who appears to be a hired gun for biotechs. Who will come on board with paracelsian when the company has been so decimated professionally at this point?
I think whoever they bring on board for the CSO officer, the CFO, and Dr. Aids will need a mega sweet deal. IMHO, those three positions will cost Paracelsian a pretty penny.
Besides 50 other worries, I wonder if Paracelsian is contracting out to someone to prepare their latest qt reports. I believe thats required for SEC...
This week, I will call the company and ask for their 3/31 cash position. If its well over $2 million, they should be just fine rolling out AndroVir. Speaking of rolling out AndroVir, Paul isn't it true that Paracelsian will roll it out to selected cities? It will not be a nationwide thing, and I also believe, they are going to rely on word of mouth for most of their advertising. Correct Paul? if so, I wonder how this affects thir sales projections????
Rick D |